PUBLICATIONS · 28548706
45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2017 Sep
- First author
- Ermoian RP
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Pediatr Blood Cancer. 2018 Jun;65(6):e27058. doi: 10.1002/pbc.27058.
- note
- Source null
- related pmid
- 29679530
- relationship
- Erratum in
- citation
- Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):963-966. doi: 10.1016/j.ijrobp.2019.04.022.
- note
- Source null
- related pmid
- 31327424
- relationship
- Comment in
Authors and identifiers
- name
- Ermoian RP
- type
- Author
- name
- Breneman J
- type
- Author
- name
- Walterhouse DO
- type
- Author
- name
- Chi YY
- type
- Author
- name
- Meza J
- type
- Author
- name
- Anderson J
- type
- Author
- name
- Hawkins DS
- type
- Author
- name
- Hayes-Jordan AA
- type
- Author
- name
- Parham DM
- type
- Author
- name
- Yock TI
- type
- Author
- name
- Donaldson SS
- type
- Author
- name
- Wolden SL
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Ermoian RP
- type
- Author
- name
- Breneman J
- type
- Author
- name
- Walterhouse DO
- type
- Author
- name
- Chi YY
- type
- Author
- name
- Meza J
- type
- Author
- name
- Anderson J
- type
- Author
- name
- Hawkins DS
- type
- Author
- name
- Hayes-Jordan AA
- type
- Author
- name
- Parham DM
- type
- Author
- name
- Yock TI
- type
- Author
- name
- Donaldson SS
- type
- Author
- name
- Wolden SL
- type
- Author
- bibliography ids
- nci-bib-8fed36022c94064ece63f537
- book metadata
- content sha256
- 997bbb1996347169c06f2c31c2470abb95ef042b912b4a3336f2391116056a07
- document type
- citation
- dois
- 10.1002/pbc.26540
- electronic publication date
- display
- 2017 May 26
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28548706
- immutable id
- pubmed:28548706@997bbb1996347169c06f2c31c2470abb95ef042b912b4a3336f2391116056a07
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 9
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- Source null
- volume
- 64
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Pediatr Blood Cancer. 2018 Jun;65(6):e27058. doi: 10.1002/pbc.27058.
- note
- Source null
- related pmid
- 29679530
- relationship
- Erratum in
- citation
- Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):963-966. doi: 10.1016/j.ijrobp.2019.04.022.
- note
- Source null
- related pmid
- 31327424
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 28548706
- provenance
- batch id
- 1c173f0e18be0c6d461b
- provider
- NCBI PubMed ESummary
- record sha256
- 83f443e748c5299861a590acd34c9ac3caf498339a03c3f8aa0484125087a4a0
- response sha256
- 27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
- retrieved at
- 2026-09-09T23:47:25.975513+00:00
- publication date
- display
- 2017 Sep
- precision
- month
- year
- 2017
- publication types
- Clinical Trial
- Historical Article
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Preserved source evidence · Not medical advice
Triangle